These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11027613)

  • 41. Interaction of copper(II) with the prion peptide fragment HuPrP(76-114) encompassing four histidyl residues within and outside the octarepeat domain.
    Di Natale G; Osz K; Nagy Z; Sanna D; Micera G; Pappalardo G; Sóvágó I; Rizzarell E
    Inorg Chem; 2009 May; 48(9):4239-50. PubMed ID: 19348438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of Cu2+-binding modes in the prion protein by visible circular dichroism and multivariate curve resolution.
    Pollock JB; Cutler PJ; Kenney JM; Gemperline PJ; Burns CS
    Anal Biochem; 2008 Jun; 377(2):223-33. PubMed ID: 18381199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure and stability of the CuII complexes with tandem repeats of the chicken prion.
    Stanczak P; Valensin D; Juszczyk P; Grzonka Z; Migliorini C; Molteni E; Valensin G; Gaggelli E; Kozlowski H
    Biochemistry; 2005 Oct; 44(39):12940-54. PubMed ID: 16185063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Copper deficiency in the young bovine results in dramatic decreases in brain copper concentration but does not alter brain prion protein biology.
    Legleiter LR; Spears JW; Liu HC
    J Anim Sci; 2008 Nov; 86(11):3069-78. PubMed ID: 18599661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De novo design of a copper(II)-binding helix-turn-helix chimera: the prion octarepeat motif in a new context.
    Shields SB; Franklin SJ
    Biochemistry; 2004 Dec; 43(51):16086-91. PubMed ID: 15610003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On-column purification and refolding of recombinant bovine prion protein: using its octarepeat sequences as a natural affinity tag.
    Yin SM; Zheng Y; Tien P
    Protein Expr Purif; 2003 Nov; 32(1):104-9. PubMed ID: 14680946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calreticulin inhibits prion protein PrP-(23-98) aggregation in vitro.
    Shiraishi N; Inai Y; Hirano Y; Ihara Y
    Biosci Biotechnol Biochem; 2011; 75(8):1625-7. PubMed ID: 21821925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metal imbalance and compromised antioxidant function are early changes in prion disease.
    Thackray AM; Knight R; Haswell SJ; Bujdoso R; Brown DR
    Biochem J; 2002 Feb; 362(Pt 1):253-8. PubMed ID: 11829763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant prion protein does not possess SOD-1 activity.
    Jones S; Batchelor M; Bhelt D; Clarke AR; Collinge J; Jackson GS
    Biochem J; 2005 Dec; 392(Pt 2):309-12. PubMed ID: 16156720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Copper(II) inhibits in vitro conformational conversion of ovine prion protein triggered by low pH.
    Liu ML; Li YX; Zhou XM; Zhao DM
    J Biochem; 2008 Mar; 143(3):333-7. PubMed ID: 18039688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Copper-dependent functions for the prion protein.
    Brown DR; Sassoon J
    Mol Biotechnol; 2002 Oct; 22(2):165-78. PubMed ID: 12405264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mapping the functional domain of the prion protein.
    Cui T; Daniels M; Wong BS; Li R; Sy MS; Sassoon J; Brown DR
    Eur J Biochem; 2003 Aug; 270(16):3368-76. PubMed ID: 12899694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of a polymerized prion protein.
    Lu BY; Chang JY
    Biochem J; 2002 May; 364(Pt 1):81-7. PubMed ID: 11988079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative analysis of heparin affecting the biochemical properties of chicken and murine prion proteins.
    Wang LJ; Gu XD; Li XX; Shen L; Ji HF
    PLoS One; 2021; 16(2):e0247248. PubMed ID: 33600459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of a recombinant full-length prion protein in a soluble form without refolding or detergents.
    Arii Y; Oshiro S; Wada K; Fukuoka S
    Biosci Biotechnol Biochem; 2011; 75(6):1181-3. PubMed ID: 21670515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quercetin binding accelerates prion fibrillation into proteinase sensitive and loosely structured amyloids.
    Yu KH; Jheng CP; Lee CI
    Biomed Pharmacother; 2022 Jul; 151():113177. PubMed ID: 35676783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Copper-induced conformational change in a marsupial prion protein repeat peptide probed using FTIR spectroscopy.
    Gustiananda M; Haris PI; Milburn PJ; Gready JE
    FEBS Lett; 2002 Feb; 512(1-3):38-42. PubMed ID: 11852048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insights into potentially toxic effects of 4-aminoantipyrine on the antioxidant enzyme copper-zinc superoxide dismutase.
    Teng Y; Liu R
    J Hazard Mater; 2013 Nov; 262():318-24. PubMed ID: 24056243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural underpinnings of prion protein conversion.
    Apostol MI; Surewicz WK
    J Biol Chem; 2011 May; 286(21):le7; author reply Ie8. PubMed ID: 21602283
    [No Abstract]   [Full Text] [Related]  

  • 60. Copper induces structural changes in N-terminus of human prion protein.
    Lu B; Zhao L; Qin K
    Biochem Biophys Res Commun; 2018 May; 499(3):470-474. PubMed ID: 29580990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.